levodopa has been researched along with morphine in 56 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (39.29) | 18.7374 |
| 1990's | 7 (12.50) | 18.2507 |
| 2000's | 13 (23.21) | 29.6817 |
| 2010's | 12 (21.43) | 24.3611 |
| 2020's | 2 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Agnati, L; Dafeldecker, WP; Fuxe, K; Guarino, J; Kosersky, DS; Neumeyer, JL; Reinhard, JF | 1 |
| Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
| Jolivette, LJ; Ward, KW | 1 |
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Barber, S; Dew, TP; Farrell, TL; Poquet, L; Williamson, G | 1 |
| Hosoya, E; Oka, T | 1 |
| Cohen, KL | 1 |
| McGilliard, KL; Takemori, AE | 1 |
| Bissada, NK; Finkbeiner, AE; Welch, LT | 1 |
| Kameyama, T; Nabeshima, T | 1 |
| Eidelberg, E; Erspamer, R | 1 |
| de Wied, D; Spaapen-Kok, WB; Van Ree, JM; Versteeg, DH | 1 |
| Dent, R; Guyda, H; Tolis, G | 1 |
| Aiello-Malmberg, P; Bartolini, A; Bartolini, R; Galli, A | 1 |
| Strömbom, U; Svensson, TH | 1 |
| Cuparencu, B; Sandor, V | 1 |
| Clouet, DH; Iwatsubo, K | 1 |
| Blum, K; Hirst, M; Marshall, A | 1 |
| Doi, T; Kawasaki, K; Takagi, H | 1 |
| Kuschinsky, K | 1 |
| Sparber, SB; Takemori, AE; Tulunay, FC | 1 |
| Kim, HS; Kim, SH; Oh, KW; Rheu, HM | 1 |
| Akane, A; Fukushima, S; Kobayashi, S; Matsubara, K; Shiono, H | 1 |
| Frey, HH; Voits, M | 1 |
| Ceresoli, G; Groppetti, A; Mandelli, V; Parenti, M | 1 |
| Rubenson, A; Sillén, U | 1 |
| Bhattacharya, SK; Parmar, SS | 1 |
| Forney, E; Klemm, WR | 1 |
| Ghosh, MN; Gopalakrishnan, V; Pillai, NP; Ramaswamy, S | 2 |
| Kunihara, M; Nakano, M; Ohyama, M | 1 |
| el-Kadi, AO; Sharif, SI | 1 |
| Becker, G; Berg, D; Reiners, K | 1 |
| Becker, G; Berg, D; Naumann, M; Reiners, K | 1 |
| Mantione, KJ; Shen, L; Stefano, GB; Zhu, W | 1 |
| Boettcher, C; Dräger, B; Fellermeier, M; Zenk, MH | 1 |
| Chung, SJ; Lee, HT; Seo, EK; Shim, CK | 1 |
| Baggerman, G; Cadet, P; Mantione, KJ; Stefano, GB; Zhu, W | 1 |
| Hnasko, TS; Palmiter, RD; Sotak, BN | 1 |
| Kream, RM; Ptáček, R; Stefano, GB | 1 |
| Almeida, OF; Araújo, D; Cardona, D; Carvalho, AF; Carvalho, MM; Costa, BM; Leão, P; Morgado, P; Oliveira, M; Palha, JA; Pêgo, JM; Rodrigues, AJ; Sousa, N | 1 |
| Esch, T; Králíčková, M; Kream, RM; Kuzelova, H; Mantione, KJ; Ptacek, R; Stefano, GB | 1 |
| Borrelli, E; Calcagno, M; Marti, M; Morari, M; Viaro, R | 1 |
| Roczniak, W | 1 |
| Hu, X; Huang, B; Li, H; Ma, Y; Rizak, JD; Yan, T; Yang, S | 1 |
| Babuśka-Roczniak, M; Brodziak-Dopierała, B; Cipora, E; Kwapuliński, J; Nowak, P; Oświęcimska, JM; Roczniak, W; Widuchowski, W | 1 |
| Bartlett, MJ; Falk, T; Heien, ML; Parent, KL; Polt, R; Sherman, SJ; Skinner, DP; So, LY; Szabò, L; Vanderah, TW | 1 |
| Adamski, P; Buszko, K; Gasior, M; Gorący, J; Kleinrok, A; Kosobucka, A; Kubica, A; Kubica, J; Lesiak, M; Nadolny, K; Navarese, E; Niezgoda, P; Wojakowski, W | 1 |
4 review(s) available for levodopa and morphine
| Article | Year |
|---|---|
Metabolic, endocrine, and drug-induced interference with pituitary function tests: a review.
Topics: Anorexia; Antipsychotic Agents; Depression; Diabetes Mellitus; Drug-Related Side Effects and Adverse Reactions; Endocrine System Diseases; Ethanol; Hormones; Humans; Hypokalemia; Levodopa; Liver Cirrhosis; Metabolic Diseases; Morphine; Obesity; Phenothiazines; Pituitary Function Tests; Pituitary Gland; Starvation; Uremia | 1977 |
Uropharmacology: X. Central nervous system stimulants and depressants.
Topics: Amphetamines; Anesthetics; Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Baclofen; Benzodiazepines; Central Nervous System Agents; Chloral Hydrate; Humans; Imipramine; Levodopa; Meperidine; Meprobamate; Morphine; Nortriptyline; Paraldehyde; Phenothiazines; Phenytoin; Picrotoxin; Reserpine; Strychnine; Urinary Tract | 1979 |
Psychiatric implications of endogenous morphine: up-to-date review.
Topics: Animals; Catecholamines; Dopamine; Humans; Leukocytes; Levodopa; Morphine; Morphine Dependence; Mytilus edulis; Nitric Oxide; Opioid Peptides; Signal Transduction; Tyrosine | 2010 |
Parkinson's disease, L-DOPA, and endogenous morphine: a revisit.
Topics: Animals; Codeine; Humans; Levodopa; Morphine; Parkinson Disease; Tetrahydropapaveroline | 2012 |
2 trial(s) available for levodopa and morphine
| Article | Year |
|---|---|
Morphine in tardive and idiopathic dystonia (short communication).
Topics: Adult; Aged; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Levodopa; Middle Aged; Morphine; Neostriatum; Pain; Parkinson Disease; Pilot Projects; Receptors, Dopamine; Treatment Outcome | 2001 |
ANalgesic Efficacy and safety of MOrphiNe versus methoxyflurane in patients with acute myocardial infarction: the rationale and design of the ANEMON-SIRIO 3 study: a multicentre, open-label, phase II, randomised clinical trial.
Topics: Acute Coronary Syndrome; Analgesics; Carbidopa; Drug Combinations; Humans; Levodopa; Methoxyflurane; Morphine; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Treatment Outcome | 2021 |
50 other study(ies) available for levodopa and morphine
| Article | Year |
|---|---|
Aporphines. 14 Dopaminergic and antinociceptive activity of aporphine derivatives. Synthesis of 10-hydroxyaporphines and 10-hydroxy-N-n-propylnoraporphine.
Topics: Analgesics; Animals; Aporphines; Dopamine; Humans; Male; Mice; Neural Pathways; Rats; Reaction Time; Stereotyped Behavior; Structure-Activity Relationship | 1976 |
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Predicting phenolic acid absorption in Caco-2 cells: a theoretical permeability model and mechanistic study.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Cinnamates; Enterocytes; Humans; Hydrophobic and Hydrophilic Interactions; Intestinal Absorption; Kinetics; Models, Biological; Molecular Conformation; Osmolar Concentration; Phenols | 2012 |
Effects of humoral modulators and naloxone on morphine-induced changes in the spontaneous locomotor activity of the rat.
Topics: 5-Hydroxytryptophan; Animals; Atropine; Fenclonine; Levodopa; Male; Methyltyrosines; Morphine; Motor Activity; Naloxone; Neurotransmitter Agents; Rats; Scopolamine | 1976 |
The effect of dopaminergic modifiers on morphine-induced analgesia and respiratory depression.
Topics: Analgesics, Opioid; Animals; Dopamine; Drug Interactions; Haloperidol; Levodopa; Male; Mice; Morphine; Pimozide; Reaction Time; Respiration | 1979 |
[Relationship between biogenic amines and analgesic action of difenamizole in heat induced reflexes].
Topics: 5-Hydroxytryptophan; Aminopyrine; Analgesics; Animals; Biogenic Amines; Brain Chemistry; Drug Synergism; Fenclonine; Levodopa; Male; Mice; Morphine; Pyrazoles; Rats; Reflex; Reserpine; Serotonin; Tyrosine | 1976 |
Dopaminergic mechanisms of opiate actions in brain.
Topics: Analgesics; Animals; Brain; Dopamine; Drug Synergism; Drug Tolerance; Haloperidol; Humans; Levodopa; Male; Mice; Morphine; Morphine Dependence; Motor Activity; Naloxone; Reaction Time; Synapses; Synaptic Transmission | 1975 |
Effects of morphine on hypothalamic noradrenaline and on pituitary-adrenal activity in rats.
Topics: Adrenocorticotropic Hormone; Animals; Droxidopa; Female; Hypothalamus; Levodopa; Male; Morphine; Norepinephrine; Pituitary-Adrenal System; Rats | 1976 |
Opiates, prolactin, and the dopamine receptor.
Topics: Apomorphine; Bromocriptine; Chlorpromazine; Cyproheptadine; Heroin Dependence; Humans; Kinetics; Levodopa; Methadone; Morphine; Prolactin; Receptors, Dopamine | 1978 |
Effects of morphine, physostigmine and raphe nuclei stimulation on 5-hydroxytryptamine release from the cerebral cortex of the cat.
Topics: Animals; Brain Stem; Cats; Cerebral Cortex; Dihydroxyphenylalanine; Electric Stimulation; Electroencephalography; Female; Levodopa; Male; Morphine; Physostigmine; Raphe Nuclei; Rats; Serotonin; Species Specificity | 1979 |
Antagonism of morphine-induced central stimulation in mice by small doses of catecholamine-receptor agonists.
Topics: Animals; Apomorphine; Brain; Clonidine; Dopamine; Levodopa; Male; Methyltyrosines; Mice; Morphine; Motor Activity; Norepinephrine; Parasympathomimetics | 1978 |
Analysis of the mechanism of the protective activity of some sympathomimetic amines in experimental ulcers.
Topics: Amitriptyline; Amphetamine; Animals; Apomorphine; Butyrophenones; Catecholamines; Chlorpromazine; Cocaine; Levodopa; Morphine; Pimozide; Rats; Receptors, Adrenergic; Reserpine; Restraint, Physical; Stomach Ulcer; Sympathomimetics; Trifluperidol | 1977 |
Effects of morphine and haloperidol on the electrical activity of rat nigrostriatal neurons.
Topics: Action Potentials; Animals; Apomorphine; Caudate Nucleus; Corpus Striatum; Haloperidol; Injections; Injections, Intravenous; Levodopa; Male; Morphine; Narcotic Antagonists; Neurons; Rats; Substantia Nigra; Time Factors | 1977 |
Analgesic effects of 3-carboxysalsolinol alone and in combination with morphine.
Topics: Analgesia; Animals; Carbidopa; Dose-Response Relationship, Drug; Drug Synergism; Isoquinolines; Levodopa; Mice; Morphine; Naloxone; Salsoline Alkaloids | 1977 |
Effects of morphine, L-DOPA and tetrabenazine on the lamina V cells of spinal dorsal horn.
Topics: Animals; Bradykinin; Brain Stem; Electric Stimulation; Levodopa; Microelectrodes; Morphine; Pain; Rabbits; Receptors, Adrenergic; Spinal Cord; Tetrabenazine | 1975 |
Does chronic morphine treatment induce a supersensitivity of dopamine receptors in rat brain?
Topics: Animals; Apomorphine; Benserazide; Brain; Corpus Striatum; Dopamine; Homovanillic Acid; Humans; Levodopa; Male; Morphine; Probenecid; Rats; Receptors, Drug; Stereotyped Behavior; Substance Withdrawal Syndrome | 1975 |
The effect of dopaminergic stimulation and blockade on the nociceptive and antinociceptive responses of mice.
Topics: Analgesics; Animals; Apomorphine; Depression, Chemical; Dopamine; Haloperidol; Levodopa; Male; Mice; Morphine; Naloxone; Pain; Pimozide; Reaction Time; Receptors, Drug; Stimulation, Chemical | 1975 |
Antagonism of U-50,488H-induced antinociception by ginseng total saponins is dependent on serotonergic mechanisms.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Dihydroxyphenylalanine; Levodopa; Male; Mice; Mice, Inbred ICR; Morphine; Naloxone; Panax; Plants, Medicinal; Pyrrolidines; Reaction Time; Saponins; Serotonin | 1992 |
Increased urinary morphine, codeine and tetrahydropapaveroline in parkinsonian patient undergoing L-3,4-dihydroxyphenylalanine therapy: a possible biosynthetic pathway of morphine from L-3,4-dihydroxyphenylalanine in humans.
Topics: Adult; Alcohol Drinking; Codeine; Humans; Levodopa; Male; Morphine; Pain; Parkinson Disease; Tetrahydropapaveroline | 1992 |
Effect of psychotropic agents on a model of absence epilepsy in rats.
Topics: Animals; Antidepressive Agents; Dextroamphetamine; Electroencephalography; Epilepsy; Female; Levodopa; Male; Memantine; Morphine; N-Methylaspartate; Parasympatholytics; Psychotropic Drugs; Rats; Rats, Inbred Strains | 1991 |
Role of opiates in striatal D-1 dopamine receptor supersensitivity induced by chronic L-dopa treatment.
Topics: Adenylyl Cyclases; Animals; Apomorphine; Corpus Striatum; Drug Interactions; Hydroxydopamines; Levodopa; Male; Morphine; Naltrexone; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Opioid | 1990 |
Central and peripheral motor effects of morphine on the rat urinary bladder.
Topics: Acetylcholine; Animals; Carbidopa; Dose-Response Relationship, Drug; Electric Stimulation; Injections, Intra-Arterial; Injections, Intraventricular; Levodopa; Male; Morphine; Muscle Contraction; Muscle, Smooth; Naloxone; Pelvis; Rats; Rats, Inbred Strains; Substance P; Urinary Bladder | 1986 |
Stress by restraining potentiates morphine catalepsy in rats.
Topics: 5,6-Dihydroxytryptamine; Animals; Benserazide; Catalepsy; Diclofenac; Ditiocarb; Drug Interactions; Fenclonine; Hemicholinium 3; Levodopa; Male; Mefenamic Acid; Morphine; Naloxone; Rats; Rats, Inbred Strains; Restraint, Physical; Stress, Physiological | 1985 |
Unit activity indicators of a catecholamine role in expression of morphine effects.
Topics: Animals; Caudate Nucleus; Evoked Potentials; Gyrus Cinguli; Hippocampus; Levodopa; Limbic System; Locus Coeruleus; Male; Morphine; Neural Pathways; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, Dopamine; Substantia Nigra | 1983 |
Effect of cholinergic agonists and antagonists on jumping behaviour induced by morphine and L-dopa in mice.
Topics: Animals; Atropine; Atropine Derivatives; Levodopa; Male; Mice; Morphine; Motor Activity; Neostigmine; Parasympatholytics; Parasympathomimetics; Physostigmine | 1984 |
L-Dopa induced jumping behaviour in acutely morphinized mice.
Topics: Animals; Humans; Levodopa; Male; Mice; Morphine; Motor Activity; Substance Withdrawal Syndrome | 1981 |
Effects of spiradoline mesylate, a selective kappa-opioid-receptor agonist, on the central dopamine system with relation to mouse locomotor activity and analgesia.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Brain; Brain Stem; Cerebral Cortex; Corpus Striatum; Dopamine; Haloperidol; Levodopa; Male; Methamphetamine; Mice; Morphine; Motor Activity; Pyrrolidines | 1993 |
The role of dopamine in the expression of morphine withdrawal.
Topics: Adrenergic Agents; Analgesia; Analgesics, Opioid; Analysis of Variance; Animals; Apomorphine; Dopamine; Dopamine Agents; Dopamine Antagonists; Hypothermia; Levodopa; Male; Mice; Morphine; Naloxone; Narcotic Antagonists; Oxidopamine; Substance Withdrawal Syndrome | 1998 |
Reduction of dyskinesia and induction of akinesia induced by morphine in two parkinsonian patients with severe sciatica.
Topics: Aged; Analgesics, Opioid; Antiparkinson Agents; Dyskinesia, Drug-Induced; Humans; Hypokinesia; Intervertebral Disc Displacement; Levodopa; Lumbar Vertebrae; Male; Middle Aged; Morphine; Parkinson Disease; Sciatica | 1999 |
In vivo and in vitro L-DOPA and reticuline exposure increases ganglionic morphine levels.
Topics: Alkaloids; Animals; Benzylisoquinolines; Bivalvia; Ganglia; In Vitro Techniques; Levodopa; Morphine | 2005 |
How human neuroblastoma cells make morphine.
Topics: Alkaloids; Benzylisoquinolines; Carbon Isotopes; Cell Line, Tumor; Dopamine; Enzymes; Gas Chromatography-Mass Spectrometry; Humans; Levodopa; Models, Chemical; Morphine | 2005 |
Effect of an aqueous extract of dried immature fruit of Poncirus trifoliata (L.) Raf. on intestinal transit in rodents with experimental gastrointestinal motility dysfunctions.
Topics: Animals; Atropine; Fruit; Gastrointestinal Motility; Levodopa; Male; Mice; Mice, Inbred ICR; Morphine; Phytotherapy; Plant Extracts; Poncirus; Rats; Rats, Sprague-Dawley | 2005 |
Human white blood cells synthesize morphine: CYP2D6 modulation.
Topics: Base Sequence; Cytochrome P-450 CYP2D6; Humans; Image Processing, Computer-Assisted; Levodopa; Molecular Sequence Data; Morphine; Neutrophils; Radioimmunoassay; Reverse Transcriptase Polymerase Chain Reaction | 2005 |
Morphine reward in dopamine-deficient mice.
Topics: Analgesics, Opioid; Animals; Brain; Caffeine; Dihydroxyphenylalanine; Dopamine; Dose-Response Relationship, Drug; Levodopa; Mice; Morphine; Motor Activity; Pain; Pain Threshold; Reward; Tail; Tyrosine 3-Monooxygenase | 2005 |
Mechanisms of initiation and reversal of drug-seeking behavior induced by prenatal exposure to glucocorticoids.
Topics: Animals; Cell Count; DNA Methylation; Dopamine; Drug-Seeking Behavior; Female; Gene Expression; Glucocorticoids; Levodopa; Male; Morphine; Neuronal Plasticity; Nucleus Accumbens; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Receptors, Dopamine D2 | 2012 |
Pharmacological and genetic evidence for pre- and postsynaptic D2 receptor involvement in motor responses to nociceptin/orphanin FQ receptor ligands.
Topics: Analgesics, Opioid; Animals; Carbamates; Catalepsy; Dopamine Agents; Dopamine Antagonists; Dose-Response Relationship, Drug; Levodopa; Ligands; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Morphine; Motor Activity; Nociceptin; Opioid Peptides; Receptors, Dopamine D2; Rotarod Performance Test | 2013 |
Assessment of dopamine (DA) synthesis rate in selected parts of the rat brain with central noradrenergic lesion after administration of 5-HT3 receptor ligands.
Topics: Adrenergic Neurons; Animals; Benzylamines; Brain Injuries; Brain Stem; Carboxy-Lyases; Dopamine; Frontal Lobe; Hypothalamus; Levodopa; Male; Morphine; Ondansetron; Rats; Rats, Wistar; Receptors, Serotonin, 5-HT3; Thalamus | 2013 |
Acute morphine treatments alleviate tremor in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Hypokinesia; Levodopa; Macaca mulatta; Male; Morphine; Motor Activity; Parkinson Disease; Postural Balance; Tremor | 2014 |
The effect of central noradrenergic system lesion on dopamine (DA) and serotonin (5-HT) synthesis rate following administration of 5-HT3 receptor ligands in chosen parts of the rat brain.
Topics: Analgesics, Opioid; Animals; Autonomic Nervous System Diseases; Benzylamines; Biguanides; Brain Chemistry; Cerebellum; Dopamine; Hippocampus; Levodopa; Ligands; Male; Morphine; Neurotoxins; Ondansetron; Rats; Rats, Wistar; Serotonin; Serotonin 5-HT3 Receptor Agonists; Serotonin 5-HT3 Receptor Antagonists | 2015 |
Highly-selective µ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent model.
Topics: Animals; Disease Models, Animal; Dyskinesia, Drug-Induced; Glycopeptides; Levodopa; Male; Morphine; Narcotic Antagonists; Nociception; Rats, Sprague-Dawley; Receptors, Opioid, mu | 2020 |